Top Story

Hyperparathyroidism identification lacking, surgical solutions infrequently utilized

July 15, 2019

Horizon files biologics license application for thyroid eye disease treatment

July 11, 2019
Horizon Therapeutics has submitted a biologics license application to the FDA for its investigational thyroid eye disease treatment candidate teprotumumab, according to…
In the Journals

Lower postsurgical thyroid cancer rates found among adults with obesity

July 11, 2019
A cohort of adults with obesity or morbid obesity had a lower rate of papillary thyroid malignancy after thyroid surgery than adults without obesity, according to…
In the Journals

Improved levothyroxine treatment observed in adults with obesity

July 10, 2019
An analysis of a cohort of adults with morbid obesity and primary hypothyroidism demonstrated that most were adequately treated with levothyroxine replacement therapy…
More Headlines »

Ace the Case: A 65-Year-Old Man with a History of Diabetes Mellitus and Chronic Kidney Disease, Stage 3

No commercial support for this activity.

This educational activity will discuss the management of a 65-year-old man with type 2 diabetes mellitus, uncontrolled…
More »
Meeting News

VIDEO: BLU-667, avapritinib highlight Blueprint Medicines pipeline

June 13, 2019
More »

Best of Obesity Forum® 2018

This activity is supported by an educational grant from Novo Nordisk, Inc.

The incidence of obesity has increased dramatically over the past 20 years and is considered to be an epidemic in the…
More »